Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment
7-6 | 120,707 people signed petitions urging the corporation to drop the price.
5-9 | The only European country facing an armed conflict, Ukraine's healthcare system was already under great strain, especially in the east where sporadic hostilities have left many struggling to access healthcare. The spread of COVID-19 threatens to further overwhelm the country's healthcare capacity.
6-12 | Médecins Sans Frontières (MSF) released findings from a follow-up survey of its community-based HIV/TB project in Eshowe, KwaZulu Natal.
MSF warns high prices of tuberculosis drugs restrict people´s access to best drug-resistant TB treatment
10-20 | ©MSF Calls on US pharma corporation Johnson & Johnson to cut key TB drug price in half People with drug-resistant tuberculosis (DR-TB) continue to be deprived of today’s best-possible treatment
10-18 | Kasaye sits on his bed in the intensive care unit of the MSF health centre in Abdurafi, a bottle of soda and some cookies in his hands. He looks incredibly frail and the simple acts of drinking and eating seem to require immense effort. “This is the thirteenth time that I have come to MSF for kala azar treatment,” he says. Kala azar (also known as visceral leishmaniasis) is the second largest parasitic killer after malaria, which makes it one of the most dangerous neglected tropical diseases in the world.